Omoniyi J. Adedokun

Statistics

Publications

Citations

8.1K

H-Index

Active since

2009

Affiliations

Janssen (United States)(Current)

University of California San Diego

Icahn School of Medicine at Mount Sinai

Springhouse

Western University

Omoniyi J. Adedokun is an author at Janssen (United States) specializing in inflammatory bowel disease therapy, inflammatory bowel disease, and gastrointestinal inflammation.

ORCID

Publications per year

2009–2024

Publications

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Brian G. Feagan, William J. Sandborn, Christopher Gasink et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Bruce E. Sands, William J. Sandborn, Remo Panaccione et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

William J. Sandborn, Brian G. Feagan, Colleen Marano et al. · Gastroenterology · 2013 · 928 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis

William J. Sandborn, Brian G. Feagan, Colleen Marano et al. · Gastroenterology · 2013 · 719 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis

Omoniyi J. Adedokun, William J. Sandborn, Brian G. Feagan et al. · Gastroenterology · 2014 · 333 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

1–5 of 39